Skip to Main Content

Michael D. Alvarado

MD MS

Breast cancer surgeon
Melanoma surgeon
Former semipro cyclist, current food and wine enthusiast

Dr. Michael Alvarado is a cancer surgeon who cares for patients with breast cancer and melanoma at the UCSF Helen Diller Family Comprehensive Cancer Center at Mount Zion.

In his research, Alvarado conducts trials of radiation therapy for breast cancer. He also studies blood-based and molecular markers with the goal of improving breast cancer screening.

Alvarado earned a master's degree in chemistry at the University of Arizona and a medical degree at Dartmouth College’s Geisel School of Medicine. After completing a residency at Dartmouth-Hitchcock Medical Center, he completed a surgical oncology fellowship at the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida.

  • Education

    Dartmouth Medical School, 1998

  • Residencies

    Dartmouth-Hitchcock Medical Center, Surgery, 1999

  • Fellowships

    H. Lee Moffitt Cancer Center, Surgical Oncology, 2006

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Professor

Treatments for melanoma and breast cancer are rapidly evolving, and I believe my patients deserve individualized, precision medicine incorporating shared decision-making.

Where I see patients (2)

    My reviews

    4.9

    Overall Experience
    199 Ratings
    Explained things in a way that was easy to understand
    198 Ratings
    Did the doctor pay attention to your concerns
    196 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    191 Ratings
    Knew the important information about your medical history
    195 Ratings
    The provider showed respect for what you had to say
    198 Ratings
    The provider spent enough time with me
    196 Ratings
    Decorative Caduceus

    Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Cons...

    Local tumor control is defined as no recurrent tumor in the ipsilateral breast. Patients will be regularly monitored as per the individual center's policy provided this meets the minimum trial criteria for follow-up with physical ...

    Recruiting

    Share